Dr. Tabatabai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6550 Fannin Street
Suite 1101
Houston, TX 77030Phone+1 713-441-4451Fax+1 713-790-2727- Is this information wrong?
Summary
- I am a board-certified endocrinologist specializing in osteoporosis, fractures, and metabolic bone disease. I am am an Assistant Professor of Clinical Medicine in the Division of Endocrinology, Houston Methodist Hospital in Houston, Texas and I hold academic appointments at Weill Cornell Medical College and Texas A&M University College of Medicine.
I received my medical degree, with distinction in research, at Albany Medical College in Albany, New York. My postdoctoral training included an internship and residency in internal medicine at the University of Maryland Medical Center in Baltimore and a fellowship in endocrinology at Johns Hopkins Hospital.
I am the Program Director of the Houston Methodist Endocrinology Fellowship program. I have presented educational programs and research at national meetings including the American Association of Clinical Endocrinologists (AACE), Endocrine Society, and the American Society of Bone and Mineral Research.
As the Director of the Fracture Liaison Service at Houston Methodist, I focus on coordinating treatment programs for high-risk fracture patients. I have expertise in the field of anabolic agents for treatment of fragility fractures.
I am also the Principle Investigator for the Disease Monitoring Program (UX023-CL401) at Houston Methodist for burosumab, an anti-FGF23 monoclonal antibody which corrects phosphate homeostasis in individuals with X-linked hypophosphatemic rickets. I chaired the Endocrine Society's webinar series, "Best Practices: Managing and Diagnosing Hypophosphatemia."
Education & Training
Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2012 - 2014
University of MarylandResidency, Internal Medicine, 2009 - 2012
Albany Medical CollegeClass of 2009
Certifications & Licensure
TX State Medical License 2014 - 2025
Clinical Trials
- Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS) Start of enrollment: 2015 Mar 24
- Study of the Anti-FGF23 Antibody, Burosumab, in Adults With XLH Start of enrollment: 2019 Mar 07
- Burosumab for CSHS Start of enrollment: 2019 Jul 01
Publications & Presentations
PubMed
- 4 citationsThe efficacy and safety of burosumab in two patients with cutaneous skeletal hypophosphatemia syndrome.Jeffrey Sugarman, Ann Maruri, Dale J Hamilton, Laila Tabatabai, Diana Luca, Tricia Cimms, Stan Krolczyk, Mary Scott Roberts, Thomas O Carpenter> ;Bone. 2023 Jan 1
- 1 citationsRegression of calcinosis cutis after inkless tattoo in a patient with dermatomyositis: therapeutic potential of microneedling.Yasaman Motlaghzadeh, Laila S Tabatabai, Eric Longo, Deborah E Sellmeyer> ;Osteoporosis International. 2022 Nov 1
- 4 citationsNutritional Supplements and Skeletal Health.Laila Tabatabai, Deborah E. Sellmeyer> ;Current Osteoporosis Reports. 2021 Jan 9
- Join now to see all
Press Mentions
- 6 Ways to Fight a Sugar BingeNovember 2nd, 2020
Young 35-Year-Old Men at Risk of Osteoporosis: StudyMay 30th, 2019
5 Ways to Recover from a Sugar BingeDecember 23rd, 2014- Join now to see all
Hospital Affiliations
Houston Methodist HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
